Kuopio 75 + study: Does advanced age predict more common use of psychotropics among the elderly?

International Clinical Psychopharmacology

Volumn 18, Issue 3, 2003, Pages 163-167

  Hartikainen, Sirpa ^a,b   Rahkonen, Terhi ^c   Kautiainen, Hannu ^d   Sulkava, Raimo ^a,e  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Municipal Hospitals of Kuopio   (Finland)

^c Jamsa Dist Munic Fed Hlth Care ^*  (Finland)

^d RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antidepressants; Antipsychotics; Elderly; Hypnotics; Neuroleptics; Psychotropics

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AGED; ARTICLE; CLINICAL EXAMINATION; DRUG UTILIZATION; FEMALE; FINLAND; GERIATRIC PATIENT; HEALTH SURVEY; HOME; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK;

AGED; AGED, 80 AND OVER; AGING; FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; MALE; OUTPATIENTS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; RISK FACTORS;

EID: 0038402598     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200305000-00007     Document Type: Article

References (26)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
2. Arinen S, Häkkinen U, Klaukka T, Klavus J, Lehtonen R, Aro S (1998) Health and the Use of Health Services in Finland Main Findings of the Finnish Health Care Survey 1995/96 and Changes from 1987. Helsinki: SVT Health.
3. Blazer D, Hybels C, Simonsick E, Hablot JT (2000) Sedative hypnotic and antianxiety medication use in an ageing cohort over 10 years: a racial comparison. J Am Geriatr Soc 48:1073-1079.
4. Byerly MJ, Weber MT, Brooks DL, Snow LR, Worley MA, Lescouflair E (2001) Antipsychotic medication and the elderly: effects on cognition and implication of use. Drugs Ageing 18:45-61.
5. Copeland JR, Beekman AT, Dewey ME, Hooijer C, Jordan A, Lawlor BA, et al. (1999) Depression in Europe Geographical distribution among older people. Br J Psychiatry 174:312-321.
6. Dealberto MJ, Seeman T, Mcaay GJ, Berkman L (1997) Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemil 50:357-364.
7. Ensrud KE, Blacwell TE, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, et al. (2002) Central nervous system-active medications and risk of falls in older women. J Am Geriatr Soc 50:1629-1637.
8. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
9. Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B (2001) Benzodiazepine use in an elderly community-dwelling population. Eur J Clin Pharmacol 57:419-425.
10. Giron MS, Forsell Y, Bernsten C, Thorslund M, Winblad B, Fastbom J (2002) Sleep problems in a very old population: drug use and clinical correlations. J Gerontol A Biol Sci Med Sci 57:236-240.
11. Hughes SG (1998) Prescribing for the elderly patient: why do we need to exercise caution? Br J Clin Pharmacol 46:531-533.
12. Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA (1999) Benzodiazepine use among the elderly in the community. Int J Geriat Psychiatry 14:280-284.
13. Legrain M, Lecomte T (1997) La consommation des psychotropes en France et dans quelques pays européens. Bull Acad Natl Med 181:1073-1087.
14. Linden M, Lecrubier Y, Bellatuono C, Benkert O, Kisely S, Simon G (1999) The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 19:132-140.
15. Madhusoodanan S (2001) Antipsychotic treatment of behavioural and psychological symptoms of dementia in geropsychiatric patients. Am J Geriatr Psychiatry 9:283-288.
16. Manela M, Katona C, Livinston G (1996) How common are the anxiety disorders in old age? Int J Geriatr Psychiatry 11:65-70.
17. Mannesse C, Derkx FH, de Ridder M, Manin't Veld' A, van der Cammen T (2000) Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 29:35-39.
18. ManteI-Teeuwisse AK, Klungel OH, Verschuren WM, Porsius A, de Boer A (2001). Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 54:1181-1186.
19. Mazza D, Dennerstein L, Ryan V (1995) Psychotropic drug use by women: current prevalence and associations. Med J Aust 163:86-89.
20. National Agency for Medicines (1999) Classification of Medicines (ATC) and Defined Daily Doses (DDD) 1999. Helsinki: National Agency for Medicines.
21. Päivärinta A, Verkkoniemi A, Niinistö L, Kivelä S-L, Sulkava R (1999) The prevalence and associates of depressive disorders in the oldest-old Finns. Soc Psychiatr Epidemiol 34:352-359.
22. Pietraru C, Barbui C, Poggio L, Tognoni G (2001) Antidepressant drug prescribing in Italy 2000: analysis of a general practice database. Eur J Clin Pharmacol 57:605-609.
23. Skoog I, Nilsson L, Landahl S, Steen B (1993) Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr 5:33-48.
24. Targum SD, Abbott JL (1999) Psychoses in the elderly: a spectrum of disorders. J Clin Psychiatry 60:4-10.
25. van Os J, Howard R, Takei N, Murray R (1995) Increasing age is a risk factor for psychosis in the elderly. Soc Psychiatry Psychiatr Epidemiol 30:161-164.
26. WHO (1995) Guidelines for ATC Classification and DDD Assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology.